Irinotecan—still an important player in cancer chemotherapy: a comprehensive overview

M Kciuk, B Marciniak, R Kontek - International journal of molecular …, 2020 - mdpi.com
Irinotecan has been used in the treatment of various malignancies for many years. Still, the
knowledge regarding this drug is expanding. The pharmacogenetics of the drug is the …

Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer

S Sudhesh Dev, SA Zainal Abidin… - Frontiers in …, 2021 - frontiersin.org
Receptor tyrosine kinases (RTKs) are transmembrane cell-surface proteins that act as signal
transducers. They regulate essential cellular processes like proliferation, apoptosis …

Corneal neovascularization: an anti-VEGF therapy review

JH Chang, NK Garg, E Lunde, KY Han, S Jain… - Survey of …, 2012 - Elsevier
Corneal neovascularization is a serious condition that can lead to a profound decline in
vision. The abnormal vessels block light, cause corneal scarring, compromise visual acuity …

Current methods of post-translational modification analysis and their applications in blood cancers

K Dunphy, P Dowling, D Bazou, P O'Gorman - Cancers, 2021 - mdpi.com
Simple Summary This review discusses current techniques used to study post-translational
protein modifications (PTMs) and their contribution to blood cancer research. Blood cancer …

Deep molecular response in chronic myeloid leukemia: the new goal of therapy?

FX Mahon, G Etienne - Clinical Cancer Research, 2014 - AACR
Chronic myeloid leukemia (CML) is caused by formation of the BCR–ABL1 fusion protein.
Tyrosine kinase inhibitors (TKI) that target BCR–ABL1 are now the standard of care for …

Identification of anticancer peptides from bovine milk proteins and their potential roles in management of cancer: a critical review

BNP Sah, T Vasiljevic, S McKechnie… - … Reviews in Food …, 2015 - Wiley Online Library
Cancer is the most widely recognized reason for human deaths globally. Conventional
anticancer therapies, including chemotherapy and radiation, are very costly and induce …

Muscarinic receptor agonists and antagonists: effects on cancer

ER Spindel - Muscarinic receptors, 2012 - Springer
Many epithelial and endothelial cells express a cholinergic autocrine loop in which
acetylcholine acts as a growth factor to stimulate cell growth. Cancers derived from these …

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms

M Lejman, K Kuśmierczuk, K Bednarz… - International Journal of …, 2021 - mdpi.com
Targeted therapy has revolutionized the treatment of poor-prognosis pediatric acute
lymphoblastic leukemia (ALL) with specific genetic abnormalities. It is still being described …

Kinase scaffold repurposing for neglected disease drug discovery: Discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis

G Patel, CE Karver, R Behera, PJ Guyett… - Journal of medicinal …, 2013 - ACS Publications
Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the
protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and …

Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?

J Michaelis, M Grabbert, A Sigle, M Yilmaz, D Schlager… - Cancers, 2022 - mdpi.com
Simple Summary Renal cell carcinoma (RCC) is the sixth most frequently diagnosed cancer
in men and the tenth in women with a rising incidence. The treatment of metastasized RCC …